Sector valuations DaShenLin Pharmaceutical Group Co., Ltd.
Stocks
603233
CNE100002RG2
Drug Retailers
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.40 CNY | -1.55% |
|
-0.92% | +4.43% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 14.12x | 2.64x | 0.68x | 0.58x | 4.64x | 7.65x | 4.9% | 3.09B | |
| 17.39x | 1.53x | 2.16x | 0.72x | 11.3x | 12.13x | -.--% | 15.05B | |
| 16.12x | 1.7x | 1.79x | 0.72x | 7.52x | 9.46x | 2.31% | 5.91B | |
| 13.78x | 2.07x | 0.85x | 0.88x | 6.37x | 8.34x | 3.11% | 3.9B | |
| 14.25x | 4.36x | 6.62x | 1.21x | 7.42x | 13.96x | 5.37% | 3.22B | |
| 14.62x | 6.61x | 2.23x | 0.88x | 6.64x | 9.23x | 4.39% | 2.96B | |
| 39.46x | - | 1.26x | - | - | - | - | 2.56B | |
| -91.83x | 2.89x | 1.49x | 0.46x | 17.01x | 103.36x | 0.01% | 1.51B | |
| 21.12x | 3.7x | 0.92x | 0.61x | 7.84x | 12.84x | 1.95% | 1.51B | |
| 11.72x | 0.84x | 0.11x | 0.27x | 2.67x | 5.51x | 4.33% | 928M | |
| 14.51x | 2.4x | -0.55x | 0.85x | 6.91x | 14.88x | 5.76% | 919M | |
| 42.14x | 4.02x | -6.48x | 0.98x | 12.99x | 23.28x | - | 899M | |
| 25.87x | 7.05x | 0.96x | 0.94x | 12.77x | 19.79x | 1.38% | 776M | |
| 14.5x | 1.96x | 1.2x | 0.69x | 8.48x | 13.7x | 0.36% | 705M | |
| -6.61x | 1.59x | 0.12x | 0.57x | -41.56x | -10.91x | -.--% | 620M | |
| Average | 10.74x | 3.10x | 0.89x | 0.74x | 5.07x | 17.37x | 2.6% | 2.97B | |
| Weighted average by Cap. | 14.05x | 2.56x | 1.77x | 0.76x | 8.22x | 14.30x | 2.06% |
Select your edition
All financial news and data tailored to specific country editions
